新型荧光试剂1-(8-喹啉)-3-(2-吡啶)-三氮烯的合成及其分析应用

将具有荧光特性的8-氨基喹啉和吡啶类试剂结合, 并引入杂环三氮烯结构, 合成了新型荧光试剂1-(8-喹啉)-3-(2-吡啶)-三氮烯(QPyT). 其结构经元素分析、红外光谱和核磁共振谱证实. 研究结果表明, 在碱性介质中, 该试剂在λex/λem=216 nm/343 nm处产生强荧光, 并且能被Pb(Ⅱ)猝灭. 据此建立了QPyT测定Pb(Ⅱ)的新型荧光分析法. 该方法的线性范围为1.6×10-7~1.2×10-5 mol /L, 检测限为9.0×10-8 mol/L. 将其应用于水中Pb(Ⅱ)的测定, 结果令人满意.     

1-(4-硝基苯基)-3-(3,5-二溴吡啶)三氮烯的合成及其与汞的显色反应

合成了1-(4-硝基苯基)-3-(3,5-二溴吡啶)三氮烯(NPDBPDT),并研究了NPDBPDT与汞的显色反应.在Na2B4O7-NaOH缓冲溶液(pH11.0)介质中,在Triton X-100存在下Hg(Ⅱ)与试剂生成络合物(1∶2).络合物在450 nm处有最大正吸收峰,表观摩尔吸光系数为1.36×105 L·mol-1·cm-1,在535 nm处有最大负吸收峰,表观摩尔吸光系数为1.57×105 L·mol-1·cm-1,以535 nm为参比波长,以450 nm为测量波长进行双波长测定,表观摩尔吸光系数为2.93×105 L·mol-1·cm-1.汞量在0～0.48 μg/mL范围内符合比耳定律.     

1-(4-硝基苯基)-3-(2-吡嗪)-三氮烯的合成及与镉(Ⅱ)的显色反应

报道了显色剂1-(4-硝基苯基)-3-(2-吡嗪)-三氮烯化合物的合成及其与镉(Ⅱ)的显色反应。在非离子表面活性剂Triton X-100存在下,pH 10.5的Na2B4O7-NaOH的缓冲介质中,该试剂能与镉(Ⅱ)与发生显色反应,形成摩尔比为4∶1的黄棕色配合物,配合物在波长453 nm处有最大吸收峰,表观摩尔吸光系数ε为6.90×104L.mol-1.cm-1,镉(Ⅱ)质量浓度在0~0.56μg/mL范围内遵守比尔定律。用拟定方法测不同废水中的镉(Ⅱ)。     

1-(4-硝基苯基)-3-(3,5-二溴吡啶)三氮烯的合成及其与锌的显色反应研究

新合成了吡啶类三氮烯显色剂1-(4-硝基苯基)-3-(3,5-二溴吡啶)三氮烯(NPDBPDT),并研究了NPDBPDT与锌的显色反应。在Na2B4O7-NaOH缓冲溶液(pH 10.0)介质中,于表面活性剂Triton X-100存在下,锌与试剂生成1∶2络合物。该络合物在450 nm处有最大正吸收峰,以540 nm为参比波长,450 nm为测量波长进行双峰双波长测定,其表观摩尔吸光系数为2.17×105L.mol-1.cm-1,锌含量在0~12μg/25mL范围内符合比耳定律。     

新显色剂1-(4-硝基苯基)-3-(5-氯吡啶)三氮烯的合成及其与镉的显色反应

报道了1-(4-硝基苯基)-3-(5-氯吡啶)三氮烯(NPCPDT)的合成及其与镉的显色反应研究。在Triton X-100的存在下,pH 11.5的Na2B4O7-NaOH缓冲溶液中,该试剂能与镉发生显色反应,镉与NPCPDT形成摩尔比为1∶3的黄色配合物,在440 nm处有一最大吸收,在535 nm处有一最大负吸收。以440 nm为参比波长,535 nm为测量波长进行双波长测定,表观摩尔吸光系数为2.68×105L.mol-1.cm-1,镉的质量浓度在0~0.48μg/mL范围内符合比尔定律。用拟定方法测定废水和环境水样中的微量镉。     

(-)-双(薄荷基甲酰基)苯基氧化膦的合成及在自由基光聚合中的螺旋选择性

以苯基二氯化膦和薄荷基甲酸为原料, 合成了一种手性双酰基膦氧化物光引发剂(-)-双(薄荷基甲酰基)苯基氧化膦. 采用核磁共振谱、 质谱及元素分析确定了该化合物的结构, 并测定了其螺旋诱导能力. 结果表明, (-)-BMPPO在引发自由基光聚合大位阻的单体甲基丙烯酸-1-苯基二苯并环庚酯(PDBSMA)的反应中具有螺旋选择性. 所得聚合物具有高度全同结构并显示出光学活性, 说明该聚合物形成了稳定的单手性螺旋链构象. 降低单体与引发剂的投料比及提高聚合温度有利于增加反应的螺旋选择性. 在手性薄荷醇溶剂中, 由(2,4,6-三甲基苯甲酰基)二苯基氧化膦(TPO)引发单体PDBSMA的光聚合反应也具有螺旋选择性, 但螺旋选择性很小.     

Synthesis of 1-(2,4,6-trichlorophenyl)-2-(1,2,4-triazol-4-yl)-diazene-1-oxide

By reaction of 4-amino-1,2,4-triazole with 1-nitroso-2,4,6-trichlorobenzene in the presence of excess dibromoisocyanurate the title compound was obtained.N. D. Zelinskii Institute of Organic Chemistry, Russian Academy of Sciences, 117913 Moscow. Translated from Izvestiya Akademii Nauk, Seriya Khimicheskaya, No. 2, pp. 362–364, February, 1992.     

1-(4-硝基苯基)-3-(5-硝基-2-吡啶)-三氮烯的合成及其与汞(Ⅱ)的显色反应研究

合成了 1 -(4 -硝基苯基 ) -3 -(5-硝基 -2 -吡啶 ) -三氮烯 ,并研究了它与汞(Ⅱ )的显色反应。在TritonX -1 0 0的存在下 ,pH1 1 2的Na2 B4 O7-NaOH缓冲溶液中 ,试剂与汞生成 2∶1型桔黄色配合物 ,在 4 3 8nm和 52 5nm处分别有一正一负两个吸收波峰 ,用双峰双波长测定 ,其表观摩尔吸光系数为 2 1× 1 0 5L·mo1 1·cm 1,Hg2 +的浓度在 0～ 2 80 μg/L范围内符合比耳定律。成功地测定了人发和尿液中微量的汞。     

用DCNPNPT测定江水中季铵盐型阳离子表面活性剂

利用三氮烯类试剂与季铵盐型阳离子表面活性剂形成离子缔合物可用于季铵盐型阳离子表面活性剂的测定。如用HDNPAPT[1]、HDAA[2]测定CTMAB、CPB,但其灵敏度有待提高。本文研究了显色剂1 (2,6 二氯 4 硝基苯) 3 (4 硝基苯) 三氮烯(DCNPNPT)[3]与阳离子表面活性剂的显色反应,结果表明,DCNPNPT与CTMAB、CPB反应的表观摩尔吸光系数分别为3 93×104L·mol 1·cm 1,和4 16×104L·mol 1·cm 1,是目前报道的用光度法测定季铵盐型阳离子表面活性剂较灵敏的体系之一。用此法测定了瓯江水中微量阳离子表面活性剂CTMAB、CPB的…     

1－（取代异噁唑基）－1，2，4．三唑和1－（取代嘧啶基）－1，2，4－三唑的合成及生物活性

合成了１５个新的１－（取代异噁唑基）－１，２，４－三唑和１－（取代嘧啶基）－１，２，４－三唑化合物，经元素分析、ＩＲ、１ＨＮＭＲ和ＭＳ证实其结构，并对其代表化合物进行了抑菌及植物生长调节活性的初步观察     

Organosilanes in Free Radical Cyclizations Reactions (1)

A study on the intramolecular free radical cyclization reactions mediated by diphenylsilane is described.     

1-(6-硝基-2-苯并噻唑)-3-(5-溴-8-喹啉)-三氮烯与Co(Ⅱ)的高灵敏显色反应及其应用

报道了在CPB 存在下,新试剂1-(6-硝基-2-苯并噻唑)-3-(5-溴-8-喹啉)-三氮烯(NBTBQT)与钴的显色反应.在pH 9.5的硼砂-NaOH缓冲介质中,试剂与钴形成2:1 深蓝色络合物,其最大吸收波长位于655 nm处,表观摩尔吸光系数为1.94×105 L·mol-1·cm-1,钴的质量浓度在0～0.24 mg/L 的范围内符合比尔定律.方法应用于维生素B12注射液和水系沉积物的测定.     

Synthesis of 1-(alkylamino)- and 1-(dialkylamino)benzimidazoline-2-thiones

Unlike 1-aminobenzimidazoles, 1-alkylaminobenzimidazoles are thiolated on fusing with sulfur without elimination of theN-amino group, yielding the previously unknown 1-(alkylamino)benzimidazoline-2-thiones. These compounds can be more conveniently obtained on a preparative scale by thiolation of 1-alkylacetamidobenzimidazoles with subsequent hydrolytic elimination of the acetyl group. When 1-(dialkylamino)benzimidazoles are fused with sulfur, they are converted into 1-(dialkylamino)benzimidazoline-2-thiones. By alkylation of 1-(methylamino)- and 1-(diethylamino)benzimidazoline-2-thiones with methyl iodide in alkaline media the corresponding 2-(methylthio)benzimidazoles were prepared.Translated fromIzvestiya Akademii Nauk. Seriya Khimicheskaya, No. 11, pp. 2231–2235, November, 1995.The authors are grateful to the Contest Center of Basic Natural Science at St. Petersburg University for financial support of this study.     

1-(2-Quinoxalyl)-, 1-[3,5-Di(trifluoromethyl)phenyl]-, 1-(2-Carboxyphenyl)-, and 1-Ethoxycarbonyl-4-oxo-4,5,6,7-tetrahydroindazoles

The corresponding 1-(2-quinoxalyl)-, 1-[3,5-di(trifluoromethyl)phenyl]-, and 1-ethoxycarbonyl-3-methyl-4-oxo-4,5,6,7-tetrahydroindazoles have been obtained from reactions of 2-acetyl-1,3-cyclohexanedione, its 5,5-dimethyl and 5-(2-furyl) derivatives, with 2-hydrazinoquinoxaline, 3,5-di(trifluoromethyl)phenylhydrazine, and ethoxycarbonylhydrazine. On interaction with ethoxycarbonylhydrazine the intermediate 2-[1-(-ethoxycarbonyl)hydrazino]ethylidene-1,3-cyclohexanediones were also isolated. From the potassium salt of 2-formyldimedone and 2-carboxyphenylhydrazine hydrochloride, 2-(2-carboxyphenyl)hydrazinomethylene-5,5-dimethyl-1,3-cyclohexanedione was obtained, the cyclization of which in ethanol in the presence of HCl led to 1-(2-carboxyphenyl)- and 1-(2-ethoxycarbonylphenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydroindazole.     

Synthesis, Crystal Structure and Antitumor Activity of （E）-4-tert-Butyl-N-（2,4-dichlorobenzylidene）-5-（1,2,4-triazol-1-yl）-thiazol-2-amine

The title compound (E)-4-tert-butyl-N-(2,4-dichlorobenzylidene)-5-(1,2,4-triazol-1-yl)-thiazol-2-amine was synthesized by the reaction of 4-tert-butyl-5-(1,2,4-triazol-1-yl)-thiazol-2-amine with 2,4-dichlorobenzaldehyde, and its crystal structure was determined by singlecrystal X-ray diffraction. The crystal belongs to the triclinic system, space group P1 with a = 7.9748(4), b = 10.1803(5), c = 11.4603(6), α = 102.882(1), β = 100.253(1), γ = 104.457(1)°, V = 850.95(7)3, Z = 2, F(000) = 392, C16H15Cl2N5S, Mr = 380.29, Dc = 1.484 g/cm3, S = 1.095, μ = 0.512 mm-1, the final R = 0.0301 and wR = 0.0965 for 3334 observed reflections (I 2σ(I)). The preliminary antitumor activity shows that for the title compound the IC50 of Hela is 0.175 μmol/mL and that of Bel7402 is 0.156 μmol/mL.     

A Novel Synthesis of 1-Aminoalkanephosphonic Acid Derivatives from 1-(N-Acylamino)- alkyltriphenylphosphonium Salts

Efficient and convenient procedures for the α-amidoalkylation of trialkylphosphites with 1-(N-acylamino)alkyltriphenylphosphonium salts followed by a Michaelis–Arbuzov-type reaction to afford 1-(N-acylamino)alkanephosphonic acid esters have been developed. High yields and simple isolation and purification protocols are the main advantages of this method.     

Synthesis and Molecular Structure of (E)-1-(Morpholino)-2-(thiomethyl)-2-phenylvinylphosphonate

1 INTRODUCTION Phosphorus-containing vinyl compounds havebeen widely studied due to their versatile physiolo-gical activities and applications in transition metalchemistry, asymmetric catalysis and photorearrange-ment[1～4]. In our previous papers, we have reportedthe syntheses of 2,2,4,5-tetrasubstituted-1,3-dithio-les[5] and 2,5-bis(morpholino)-3,4-bis-(p-chloro-phe-nyl)thiophenes[6] by the reactions of α-thioaroyl-thiofor-mamide with trimethyl phosphite at room tempera-ture and in refl…     

A linear trinuclear cobalt(II) complex with 4-(2-pyridine)-1,2,4-triazole: synthesis,structure and characterization

The linear trinuclear cobalt(II) complex [Co₃(pytrz)₆(H₂O)₆](NO₃)₆ (1) with pytrz = 4-(2-pyridine)-1,2,4-triazole has been prepared and characterized. It crystallizes in the rhombohedral R-3 space group with Z = 3, a = 13.955(2), b = 13.955(2), c = 28.942(9) Å, γ = 120°, V = 4881.2(18) ų. The structure of 1 comprises the cation [Co₃(pytrz)₆(H₂O)₆]⁶⁺, in which linear trinuclear Co(II) units are bridged by six L ligands and have six aqua molecules as terminal ligands. The six free nitrates link the terminal aqua ligands through N–H ··· O hydrogen bonds with C₃ symmetry. 1 was characterized by FT-IR, electronic spectra and magnetic measurements. The variable-temperature magnetic measurements reveal weak anti-ferromagnetic interactions in 1.     

Synthesis,Crystal Structure and Antitumor Activity of 4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)-N-(2-hydroxy-3,5-diiodinebenzyl)-thiazol-2-amine

The title compound, 4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)-N-(2-hydroxy-3,5-diiodinebenzyl)thiazol-2-amine, was synthesized via the reduction of 4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)-N-benzylidene-thiazol-2-amine with Na BH4, and its crystal structure was determined by single-crystal X-ray diffraction. The compound crystallizes in monoclinic system, space group P21/c with a = 7.91944(19), b = 10.5250(3), c = 24.4985(6) , Z = 4, V = 2041.66(9) 3, Mr = 599.22, Dc = 1.949 Mg/m3, S = 1.120, μ = 3.203 mm-1, F(000) = 1152, the final R = 0.0283 and wR = 0.0592 for 3490 observed reflections(Ⅰ 2σ(Ⅰ)). X-ray analysis displays that the crystal water takes part in three intermolecular hydrogen bonds of O(2)–H(2A)···O(1), O(2)–H(2B)···N(1) and N(5)–H(5)···O(2), and an octatomic ring is formed via intramolecular hydrogen bond of O(1)–H(1A)···N(4). Furthermore, the Ⅰ···Ⅰ contacts are involved in stabilizing the overall three-dimensional network structure. The preliminary biological test shows the title compound has good antitumor activity with the IC50 value of 26 μM against the Hela cell line.